[Clinical study of teicoplanin in the treatment of patients with gram-positive cocci: the Chinese experience].

Objective: To evaluate the efficacy and safety of Teicoplanin (TEC) in the treatment of Chinese patients with moderate and severe Gram positive (G(+)) coccus infections.

Methods: A prospective, multicenter, non-comparator control, open-label drug clinical trial of phase IV was conducted.

Results: Totally 156 cases with established and highly suspected G(+) coccus infections are enrolled.

[Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].

Objective: To investigate the resistance of Pseudomonas aeruginosa (P. aeruginosa) to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones (FQs).

Methods: The susceptibility of 570 strains of P.